Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic feature

Psychiatry and Clinical Neurosciences

Volumn 61, Issue 5, 2007, Pages 568-570

  Katagai, Hiroshi ^a,b   Yasui Furukori, Norio ^a   Kikuchi, Atsuhiro ^a   Kaneko, Sunao ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Hirosaki Aiseikai Hospital   (Japan)

Author keywords

Dementia; ECT; Elderly

Indexed keywords

DILTIAZEM; HALOPERIDOL; PEROSPIRONE; PROPOFOL; SUXAMETHONIUM;

AGED; ALTERNATIVE MEDICINE; ARTICLE; BISPECTRAL INDEX; BLOOD PRESSURE MONITORING; BRAIN ATROPHY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; ELECTROCARDIOGRAM; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MINI MENTAL STATE EXAMINATION; PSYCHOSIS; QT PROLONGATION;

AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; DEMENTIA, MULTI-INFARCT; ELECTROCONVULSIVE THERAPY; FEMALE; HALOPERIDOL; HUMANS; INJECTIONS, INTRAVENOUS; LONG QT SYNDROME; PSYCHOTIC DISORDERS; RISPERIDONE; TREATMENT OUTCOME;

EID: 34548691640     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2007.01709.x     Document Type: Article

References (17)

1. Meeks TW, Ropacki SA, Jeste DV. The neurobiology of neuropsychiatric syndromes in dementia. Curr. Opin. Psychiatry 2006 19 : 581 586.
2. Bassiony MM, Steinberg MS, Warren A, Rosenblatt A, Baker AS, Lyketsos CG. Delusions and hallucinations in Alzheimer's disease: Prevalence and clinical correlates. Int. J. Geriatr. Psychiatry 2000 15 : 99 107.
3. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease. Cochrane Database Syst. Rev. 2006 1 : CD003476.
4. Schneider LS, Tariot PN, Dagerman KS et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N. Engl. J. Med. 2006 355 : 1525 1538.
5. Food and Drug Administration. FDA public health advisory: Death with antipsychotics in elderly patients with behavioral disturbance. [Cited 3 November 2005.] Available from URL: http://www.fda.gov/cder/drug/advisory/ antipsychotics.htm
6. Ballard CG, Margallo-Lana ML. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. J. Clin. Psychiatry 2004 65 (Suppl. 11 23 28.
7. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment. J. Clin. Psychiatry 1987 48 (Suppl. 9 15.
8. Folstein MF, Folstein FE, McHugh PR. Mini Mental State: A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975 12 : 189 198.
9. Zareba W, Lin DA. Antipsychotic drugs and QT interval prolongation. Psychiatr. Q. 2003 74 : 291 306.
10. Weiner RD, Coffey CE, Fochtmann LJ et al. APA Task Force Report on Electroconvulsive Therapy. American Psychiatric Association, Washington, DC, 1990. Available from URL: http://www.ect.org/apa-task-force-report-on- electroconvulsive-therapy/
11. Kamholz BA, Mellow AM. Management of treatment resistance in the depressed geriatric patient. Psychiatr. Clin. North Am. 1996 19 : 269 286.
12. Burke WJ, Rubin EH, Zorumski CF, Wetzel RD. The safety of ECT in geriatric psychiatry. J. Am. Geriatr. Soc. 1987 35 : 516 521.
13. Liu J, Singh H, White PF. Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth. Analg. 1997 84 : 185 189.
14. Schneider G, Sebel PS. Monitoring depth of anaesthesia. Eur. J. Anaesthesiol. Suppl. 1997 15 : 21 28.
15. Sadean MR, Glass PS. Pharmacokinetics in the elderly. Best Pract. Res. Clin. Anaesthesiol. 2003 17 : 191 205.
16. Vuyk J. Pharmacodynamics in the elderly. Best Pract. Res. Clin. Anaesthesiol. 2003 17 : 207 218.
17. Renna M, Venturi R. Bispectral index and anaesthesia in the elderly. Minerva Anestesiol. 2000 66 : 398 402.